Shui-Ping Zhao Selected Research

Shui-Ping Zhao Research Topics

Disease

12	Coronary Disease (Coronary Heart Disease) 01/2021 - 05/2002
12	Atherosclerosis 11/2019 - 06/2003
7	Obesity 01/2016 - 12/2003
6	Dyslipidemias (Dyslipidemia) 01/2021 - 06/2003
6	Acute Coronary Syndrome 04/2014 - 05/2002
4	Insulin Resistance 01/2015 - 12/2003
4	Inflammation (Inflammations) 12/2013 - 01/2006
4	Essential Hypertension 09/2008 - 05/2005
3	Cardiovascular Diseases (Cardiovascular Disease) 07/2019 - 03/2012
3	Stroke (Strokes) 07/2019 - 04/2003
3	Hypertriglyceridemia 01/2017 - 06/2010
3	Thrombosis (Thrombus) 02/2007 - 11/2004
2	Non-alcoholic Fatty Liver Disease 01/2019 - 05/2015
2	Hypertension (High Blood Pressure) 01/2018 - 01/2016
2	Diabetes Mellitus 12/2017 - 01/2015
2	Atherosclerotic Plaque (Atheroma) 01/2017 - 06/2006
2	Coronary Artery Disease (Coronary Atherosclerosis) 08/2010 - 01/2010
1	Hyperlipidemias (Hyperlipidemia) 01/2020
1	Ischemic Stroke 07/2019
1	Intracranial Hemorrhages (Intracranial Hemorrhage) 07/2019
1	Neoplasms (Cancer) 05/2019
1	Prostatic Neoplasms (Prostate Cancer) 05/2019
1	Cardiac Arrhythmias (Arrythmia) 03/2018
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 12/2017
1	Xanthomatosis (Xanthoma) 01/2016
1	Heart Failure 10/2015
1	Muscular Diseases (Myopathy) 11/2014
1	B-Cell Lymphoma (Lymphoma, B Cell) 05/2014
1	Hepatocellular Carcinoma (Hepatoma) 12/2013
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 05/2013
1	Cardiomyopathies (Cardiomyopathy) 03/2012
1	Pneumonia (Pneumonitis) 07/2011
1	Starvation 01/2011
1	Coronary Stenosis (Coronary Artery Stenosis) 08/2010
1	Type 2 Diabetes Mellitus (MODY) 04/2010

Drug/Important Bio-Agent (IBA)

8	Triglycerides (Triacylglycerol)IBA 01/2021 - 06/2003
8	LipidsIBA 01/2020 - 09/2004
8	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 07/2019 - 06/2006
7	CholesterolIBA 01/2021 - 09/2004
5	oxidized low density lipoproteinIBA 01/2021 - 01/2004
5	xuezhikangIBA 01/2021 - 06/2003
5	LDL CholesterolIBA 01/2021 - 04/2014
4	Fenofibrate (CiL)FDA LinkGeneric 01/2020 - 09/2004
4	Apolipoprotein A-VIBA 01/2017 - 06/2010
3	red yeast riceIBA 01/2021 - 06/2003
3	Biomarkers (Surrogate Marker)IBA 01/2019 - 08/2010
3	C-Reactive ProteinIBA 06/2009 - 08/2003
3	Valsartan (Vals)FDA Link 09/2008 - 05/2005
2	HDL CholesterolIBA 01/2021 - 01/2021
2	Messenger RNA (mRNA)IBA 03/2018 - 12/2004
2	Metformin (Glucophage)FDA LinkGeneric 01/2017 - 01/2016
2	Blood Glucose (Blood Sugar)IBA 01/2017 - 04/2010
2	Atorvastatin (Lipitor)FDA Link 01/2017 - 05/2010
2	ApolipoproteinsIBA 05/2015 - 06/2009
2	Lipoproteins (Lipoprotein)IBA 05/2010 - 04/2010
2	Fluvastatin FDA Link 07/2007 - 06/2006
2	Thromboplastin (Tissue Factor)IBA 02/2007 - 11/2004
2	Plasminogen Activators (Plasminogen Activator)IBA 08/2006 - 11/2004
2	PPAR gammaIBA 12/2004 - 12/2003
2	CD40 Ligand (CD40L)IBA 09/2004 - 05/2002
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2004 - 06/2003
1	Coenzyme A (CoA)IBA 01/2020
1	Aligeron (AS 2)IBA 11/2019
1	Pharmaceutical PreparationsIBA 01/2019
1	Sirtuin 1IBA 01/2019
1	Nonesterified Fatty Acids (NEFA)IBA 01/2019
1	Antihypertensive Agents (Antihypertensives)IBA 01/2018
1	Uric Acid (Urate)IBA 12/2017
1	Glucose (Dextrose)FDA LinkGeneric 12/2017
1	FructoseIBA 01/2017
1	Simvastatin (Zocor)FDA LinkGeneric 01/2017
1	TRPC3 cation channelIBA 01/2016
1	Heparin-binding EGF-like Growth Factor (HB-EGF)IBA 01/2016
1	lipoprotein cholesterolIBA 01/2016
1	ErbB Receptors (EGF Receptor)IBA 01/2016
1	MicroRNAs (MicroRNA)IBA 01/2015
1	Transaminases (Aminotransferases)IBA 11/2014
1	Creatine Kinase (Creatine Phosphokinase)IBA 11/2014
1	Proteins (Proteins, Gene)FDA Link 05/2014
1	Peptides (Polypeptides)IBA 05/2014
1	Caspase 3 (Caspase-3)IBA 05/2014
1	OligonucleotidesIBA 12/2013
1	Fatty Acids (Saturated Fatty Acids)IBA 12/2013
1	AcidsIBA 03/2012
1	Epoxide HydrolasesIBA 03/2012
1	2-chloro-5-nitrobenzanilideIBA 01/2011
1	Peroxisome ProliferatorsIBA 01/2011
1	Fatty Acid-Binding ProteinsIBA 08/2010
1	AdiponectinIBA 08/2010
1	zhibitaiIBA 05/2010
1	PlasminogenIBA 04/2010
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 04/2010
1	Tissue Plasminogen Activator (Alteplase)FDA Link 04/2010
1	Plasminogen InactivatorsIBA 04/2010

Therapy/Procedure

7	Therapeutics 07/2019 - 05/2010
1	Autologous Blood Transfusion 05/2019
1	Operative Surgical Procedures 05/2019
1	Prostatectomy (Retropubic Prostatectomy) 05/2019
1	Surgical Instruments (Clip) 01/2016
1	Glycemic Control 04/2010